David Jackson
Chief Executive Officer Ceria Therapeutics
David M. Jackson, PhD is the CEO of Ceria Therapeutics and brings more than 25 years of experience specializing in the development and commercialization of innovative healthcare technologies addressing unmet market opportunities. He has led multiple product development efforts, fundraising campaigns, regulatory engagements and corporate transactions. Dr. Jackson earned a doctorate in the medical sciences from the Boston University School of Medicine; trained and experienced as a Patent Agent and Securities Analyst.
Seminars
Thursday 28th January 2027
Fireside Chat: Defining the Next Frontier of RNAi Therapeutics to Target Beyond the Liver
9:00 am
- Examining why extrahepatic delivery is the field’s defining challenge
- Focusing investment and research on the right bottlenecks
- Defining the milestones that will signal the arrival of truly routine extrahepatic RNAi delivery
Friday 29th January 2027
Panel Discussion: Securing Funding and Strategic Partnerships to Accelerate RNAi Innovation
11:00 am
- Understand what investors and pharmaceutical partners look for
- Learn how to find and build relationships with investors/partners interested in your field
- Gain insights into the key conferences, partnering forums and networking platforms that are shaping investment and dealmaking
